Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Meng

Showing results (381-390 of 427) with videos related to

Pageof 43
Sort By:
Journal of Medicinal Chemistry|February 28, 2007
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseasesCharles Q Meng, Liming Ni, Kimberly J Worsencroft, et al.
The Journal of Allergy and Clinical Immunology|January 12, 2000
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skinA J Macfarlane, O M Kon, S J Smith, et al.
Journal of Immunological Methods|June 19, 2001
High-throughput generation and engineering of recombinant human antibodiesB Krebs, R Rauchenberger, S Reiffert, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agentCynthia L Sundell, Patricia K Somers, Charles Q Meng, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosisCharles Q Meng, Patricia K Somers, Carolyn L Rachita, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 19, 2019
[Epidemiological characteristics of HIV/AIDS in Guangxi Zhuang Autonomous Region, 2010-2017]X M Ge, W M Yang, Q Y Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Evaluation of clinical characteristics, MYD88(L265P) mutation, CXCR4(WHIM) mutation and prognosis in Waldenström macroglobulinemia: A single center retrospective study of 93 patients]X X Cao, Q Meng, H Cai, et al.
Molecular Psychiatry|April 26, 2017
Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effectsS-X Li, Y Han, L-Z Xu, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expressionCharles Q Meng, X Sharon Zheng, Liming Ni, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2005
AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expressionCharles Kunsch, Jayraz Luchoomun, Xi-Lin Chen, et al.
Pageof 43

Showing results (381-390 of 427) with videos related to

Sort By:
Pageof 43
Journal of Medicinal Chemistry|February 28, 2007
Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseasesCharles Q Meng, Liming Ni, Kimberly J Worsencroft, et al.
The Journal of Allergy and Clinical Immunology|January 12, 2000
Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skinA J Macfarlane, O M Kon, S J Smith, et al.
Journal of Immunological Methods|June 19, 2001
High-throughput generation and engineering of recombinant human antibodiesB Krebs, R Rauchenberger, S Reiffert, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2003
AGI-1067: a multifunctional phenolic antioxidant, lipid modulator, anti-inflammatory and antiatherosclerotic agentCynthia L Sundell, Patricia K Somers, Charles Q Meng, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosisCharles Q Meng, Patricia K Somers, Carolyn L Rachita, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 19, 2019
[Epidemiological characteristics of HIV/AIDS in Guangxi Zhuang Autonomous Region, 2010-2017]X M Ge, W M Yang, Q Y Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Evaluation of clinical characteristics, MYD88(L265P) mutation, CXCR4(WHIM) mutation and prognosis in Waldenström macroglobulinemia: A single center retrospective study of 93 patients]X X Cao, Q Meng, H Cai, et al.
Molecular Psychiatry|April 26, 2017
Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effectsS-X Li, Y Han, L-Z Xu, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expressionCharles Q Meng, X Sharon Zheng, Liming Ni, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 11, 2005
AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expressionCharles Kunsch, Jayraz Luchoomun, Xi-Lin Chen, et al.
Pageof 43